Search results for: “Pharmaceuticals”
-
Telix Pharmaceuticals agrees to acquire RLS USA for upto $250 million
•
MELBOURNE: Telix Pharmaceuticals Limited (ASX: TLX) has signed an agreement to acquire RLS (USA) Inc., from its parent…
-
Hikma agrees to acquire Xellia Pharmaceuticals’ assets for $135 million
•
LONDON: Hikma Pharmaceuticals has agreed with Copenhagen based Xellia Pharmaceuticals to acquire parts of its US finished dosage…
-
Telix Pharmaceuticals launches IPO in United States
•
Melbourne: Telix Pharmaceuticals Limited (ASX: TLX) launched its initial public offering in the United States of AmericanDepositary Shares…
-
Amur Minerals Corporation acquires Extruded Pharmaceuticals
•
LONDON: Amur Minerals Corporation, now an AIM Rule 15 cash shell, has executed a sale and purchase agreement…
-
BioPharma Credit signs $200 million loan agreement with Tarsus Pharmaceuticals
•
LONDON: BioPharma Credit PLC (LSE: BPCR), a leading debt investment trust specializing in life sciences, has declared a…
-
Vertex Pharmaceuticals to acquire Alpine Immune Sciences in $4.9 billion deal
•
Vertex Pharmaceuticals Incorporated (VRTX) has announced its plans to acquire Alpine Immune Sciences, Inc. (ALPN), a company dedicated…
-
Windtree Therapeutics acquires Varian Biopharmaceuticals’ assets
•
Windtree Therapeutics, Inc. (NasdaqCM: WINT) has announced the acquisition of a novel oncology asset platform from Varian Biopharmaceuticals,…
-
Faron Pharmaceuticals appoints Dr. Juho Jalkanen as new CEO, as Dr. Markku steps down
•
TURKU, FINLAND: Faron Pharmaceuticals Ltd. (AIM: FARN), a clinical-stage biopharmaceutical company pursuing a CLEVER approach to reprogramming myeloid…
-
AstraZeneca to acquire Fusion Pharmaceuticals in a $ 2.0 billion deal
•
LONDON: AstraZeneca has entered into a definitive agreement to acquire Fusion Pharmaceuticals Inc., a clinical-stage biopharmaceutical company developing…
-
Telix Pharmaceuticals to acquire IsoTherapeutics for upto $19m
•
MELBOURNE: Telix Pharmaceuticals Limited (ASX: TLX), a company developing targeted radiopharmaceuticals for cancer diagnosis and therapy, announced today…
-
Telix Pharmaceuticals signs deal to acquire QSAM Biosciences for upto $123m
•
MELBOURNE, AUSTRALIA: Telix Pharmaceuticals Limited has entered into an agreement to acquire QSAM Biosciences, Inc. and its lead…
-
Jazz Pharmaceuticals acquires Redx’s KRAS inhibitor program
•
Alderley Park, UK: Jazz Pharmaceuticals plc and Redx Pharma plc have signed a definitive agreement under which Jazz…
Stay Informed with the Latest News and Updates
- Contact Us
- London Stock Exchange
- Singapore Exchange
- Canadian Exchange
- Australian Exchange
- Oslo Bourse
- PSX
- Ratings
- Euronext
- MENA
- Nasdaq Nordic
- Wire
- Business & Finance
- Gadget Reviews
- About Us: A Comprehensive Financial News Database
All news and articles on NewsnReleases are based on press releases, corporate announcements and analysts’ reports issued to London Stock Exchange (LSE), Euronext, Singapore Exchange (SGX), Japan Stock Exchange (JPX), Dubai Financial Market (DFM), Saudi Stock Exchange (Tadawul), Qatar Stock Exchange (QSE), BSEIndia, Australia Stock Exchange etc.